Advertisement

Central Venous Catheters and Biofilm Infections

  • Bryan Haymond
Chapter

Abstract

Central venous catheter (CVC) use has become commonplace. Infections that have plagued mankind for centuries continue to challenge medical devices, both those that are old and those that are integrated into healthcare systems. Bacterial biofilms consist of microorganisms that create an environment with multiple characteristics including a slimy matrix and varying cell types. As these communities adhere to catheter surfaces, they can cause bloodstream infections. These are problems that surgeons and healthcare workers deal with on a daily basis. We need unique and effective therapies that can be integrated with CVC devices that will eradicate biofilms, reduce patient suffering, and improve our ability to deliver necessary medications with reduced complications.

Keywords

Central venous catheter Biofilm Characteristics Infection Antimicrobial strategies 

Notes

Disclosure

The opinions and assertions included in this chapter are those of the author and do not reflect BD or affiliates.

References

  1. 1.
    Massengill, S. E. (1943). A sketch of medicine and pharmacy and a view of its progress by the Massengill family from the fifteenth to the twentieth century. SE Massengill: Bristol.Google Scholar
  2. 2.
    Smith, P. W., Watkins, K., & Hewlett, A. (2012). Infection control through the ages. American Journal of Infection Control, 40, 35–42.CrossRefGoogle Scholar
  3. 3.
    Borgognnoni, T. (1955). The surgery of Theodoric: ca AD 1267. Campbell E, Colton J, translators. New York: Appleton Century Crofts.Google Scholar
  4. 4.
    Duncan, L. C. (1931). Medical men in the American revolution, 1775e1783. Carlisle: Medical Field Service School.Google Scholar
  5. 5.
  6. 6.
    Klevens, R. M., Edwards, J. R., Richards, C. L., Horan, T. C., Gaynes, R. P., Pollock, D. A., et al. (2007). Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Reports, 122, 160–166.CrossRefGoogle Scholar
  7. 7.
  8. 8.
    Sato, et al. (2017). BMC Infectious Diseases, 17, 434.  https://doi.org/10.1186/s12879-017-2536-0.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
  10. 10.
  11. 11.
    O’Grady, N. P. et al. CDC guidelines for the prevention of intravascular catheter related infections. (2011)Google Scholar
  12. 12.
    Ash, A., et al. (2016). Seldinger Technique for placement of “peripheral” IJ lines. Western Journal of Emergency Medicine.Google Scholar
  13. 13.
    Haddadin, Y., & Regunath, H. (2018). Central Line Associated Blood Stream Infections (CLABSI) [Updated 2018 Oct 27]. In StatPearls [Internet]. Treasure Island: StatPearls Publishing. https://www.ncbi.nlm.nih.gov/pubmed/28613641.
  14. 14.
    Bowdle, A. et al, Arterial cannulation during central line placement. Mirador Biomedical Report, (2009).Google Scholar
  15. 15.
    Millennium Research Group. US Markets for Vascular Access Devices. (2011).Google Scholar
  16. 16.
    Ezaru, C., et al. (2009). Eliminating arterial injury during central venous catheterization using manometry. IARS Journal, 109(1), 130–134.Google Scholar
  17. 17.
    Zimlichman, E., Henderson, D., Tamir, O., et al. (2013). Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Internal Medicine, 173(22), 2039–2046.CrossRefGoogle Scholar
  18. 18.
    Loftus, K., Tilley, T., Hoffman, J., Bradburn, E., & Harvey, E. (2015). Use of Six Sigma strategies to pull the line n central line-associated bloodstream infections in a neurotrauma intensive care unit. Journal of Trauma Nursing, 22(2), 78–86.CrossRefGoogle Scholar
  19. 19.
    Pittet, D., et al. (1997). Microbiological factors influencing the outcome of nosocomial bloodstream infection. Clinical Infectious Diseases, 24, 1068–1078.CrossRefGoogle Scholar
  20. 20.
    Services, D. O. (2013). Action plan to prevent health care-associated Infections: Road map to elimination. Retrieved from hhs.gov
  21. 21.
    Agency for Healthcare Research and Quality. (2011). Eliminating CLABSI A National Imperative. AHRQ, 1–29.Google Scholar
  22. 22.
    CDC guidelines. (2011).Google Scholar
  23. 23.
  24. 24.
    Bell, T., & O’Grady, N. P. (2017). Prevention of Central Line-Associated Bloodstream Infections. Infectious Disease Clinics of North America, 31(3), 551–559. [PMC free article: PMC5666696] [PubMed: 28687213].CrossRefGoogle Scholar
  25. 25.
    Wassil, S. K. (2007). Antimicrobial impregnated catheters in the prevention of catheter-related bloodstream infection in hospitalized patients. Journal of Pediatric Pharmacology and Therapeutics, 12, 77–90.PubMedGoogle Scholar
  26. 26.
    McConnell, S. A., Gubbins, P. O., & Anaissie, E. J. (2003). Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clinical Infectious Diseases, 37, 65–72.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Bryan Haymond
    • 1
  1. 1.Beckton, Dickinson and Company (BD)Salt Lake CityUSA

Personalised recommendations